Mechanistically, Zepecki et al. suggested that, in glioblastoma cells, the reduced cell motility after LCK inhibition would be due to a decreased phosphorylation of Paxillin on tyrosine 118 resulting in a reduced turnover of focal adhesions [50]. The gene discussed is PXN; the disease is glioblastoma.